Correlation Between Spero Therapeutics and AN2 Therapeutics
Can any of the company-specific risk be diversified away by investing in both Spero Therapeutics and AN2 Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Spero Therapeutics and AN2 Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Spero Therapeutics and AN2 Therapeutics, you can compare the effects of market volatilities on Spero Therapeutics and AN2 Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Spero Therapeutics with a short position of AN2 Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Spero Therapeutics and AN2 Therapeutics.
Diversification Opportunities for Spero Therapeutics and AN2 Therapeutics
-0.29 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Spero and AN2 is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Spero Therapeutics and AN2 Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AN2 Therapeutics and Spero Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Spero Therapeutics are associated (or correlated) with AN2 Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AN2 Therapeutics has no effect on the direction of Spero Therapeutics i.e., Spero Therapeutics and AN2 Therapeutics go up and down completely randomly.
Pair Corralation between Spero Therapeutics and AN2 Therapeutics
Given the investment horizon of 90 days Spero Therapeutics is expected to under-perform the AN2 Therapeutics. In addition to that, Spero Therapeutics is 1.93 times more volatile than AN2 Therapeutics. It trades about -0.38 of its total potential returns per unit of risk. AN2 Therapeutics is currently generating about -0.59 per unit of volatility. If you would invest 138.00 in AN2 Therapeutics on November 5, 2024 and sell it today you would lose (29.00) from holding AN2 Therapeutics or give up 21.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Spero Therapeutics vs. AN2 Therapeutics
Performance |
| Timeline |
| Spero Therapeutics |
| AN2 Therapeutics |
Spero Therapeutics and AN2 Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Spero Therapeutics and AN2 Therapeutics
The main advantage of trading using opposite Spero Therapeutics and AN2 Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Spero Therapeutics position performs unexpectedly, AN2 Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AN2 Therapeutics will offset losses from the drop in AN2 Therapeutics' long position.| Spero Therapeutics vs. Assembly Biosciences | Spero Therapeutics vs. Achilles Therapeutics PLC | Spero Therapeutics vs. Instil Bio | Spero Therapeutics vs. CytomX Therapeutics |
| AN2 Therapeutics vs. Aerovate Therapeutics | AN2 Therapeutics vs. Adagene | AN2 Therapeutics vs. Acrivon Therapeutics, Common | AN2 Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| CEOs Directory Screen CEOs from public companies around the world |